Sunil Gairola has over 40 years of experience in various quality control, quality assurance and clinical bioanalysis roles for vaccines and biosimilars. He is the author of more than 70 publications and holds patents on vaccine development and analysis.
He is currently executive director of the Serum Institute of India and a member of the scientific staff of the Indian Pharmacopoeia and the Developing Countries Vaccine Manufacturers Network (DCVMN).